If p53 itself is mutated (as in more than 50% of human tumors), tumors may escape regulation through other pathways, but MDM2 abnormalities can still synergize with other mechanisms to accelerate cancer progression [32,33,34,35,36]. The gene discussed is TP53; the disease is cancer.